Navigating Cannabis in Clinical Practice


9 hrs





Allied Health




Allied Health

# of Credits

9 CEUs



Expiry Date


Canada has some of the highest cannabis usage in the world. Approximately 4.6 million or 15% of Canadians ≥ 15 years report using cannabis in the last 3 months.[1] This usage will likely increase as many non-cannabis users report that they plan to use cannabis in the next 3 months.[1] Approximately 50% of people report using it recreationally and the other half using it medically.[1]  With the increasing utilization of both recreational and medical use, healthcare professionals must become comfortable discussing the potential benefits and risks of cannabis.  

Are you prepared to counsel your patients?

This 6-module, in-depth certificate level education program explores the endocannabinoid system, reviews legislation in Canada including the authorization process for medical cannabis. The program also examines all evidence supporting cannabis use, the precautions clinicians should consider before initiating therapy, and recommendations for monitoring cannabis use. The final module introduces medical and recreational patient cases offering participants the opportunity to apply their learning to practice.  

Program Price: $649 + HST

[1]Statistics Canada Government of Canada. The Daily — National Cannabis Survey, fourth quarter 2018. Published February 7, 2019. Accessed June 17, 2019.

This continuing education lesson is designed primarily for pharmacists and has been accredited by the Canadian Council on Continuing Education in Pharmacy (CCCEP) for 9 CEUs. CCCEP File Number: 1066-2020-2981-I-P


Carlene Oleksyn, BSc (Pharm), CDE

Claude Cyr, MD

Michael Boivin, B. Pharm., CDE, CTE, CTH

Michael Kani, BSc, MSc, BSPhm, RPh, PharmD

With special appreciation to Mary-Ann Fitzcharles, MD, FRCPC, and the Canadian Rheumatology Association.

Module 1 - Cannabis and the Endocannabinoid System

1. Review the different Canadian legislation associated with cannabis and cannabinoids

2. Describe components of the endocannabinoid system

3. Examine the key pharmacology of cannabis 

4. Review the current prescription cannabinoids in Canada and other regions of the world

Module 2 – Cannabinoid Evidence 

1. Review the evidence supporting the prescription cannabinoids nabilone and nabiximols 

2. Discuss the key systematic reviews and guidelines regarding cannabinoid evidence 

3. Describe the cannabis position statements from a number of key associations and regulatory bodies 

Module 3 – Precautions of Cannabis Use

1. Determine the patients where cannabis is contraindicated and not recommended 

2. Counsel patients on the cannabis adverse effects 

3. Assess a patient for potential cannabis-related drug interactions 

4. Review the impact of cannabis on driving  

5. Manage a patient experiencing acute cannabis toxicity  

Module 4 – Acquiring Cannabis in Canada

1. Examine the key components of the Cannabis Act for medical and recreational cannabis  

2. Review the different groups responsible for the distribution of cannabis  

3. Review the key principles of treating patients with medical cannabis  

4. Discuss the distribution and authorization of medical cannabis in Canada 

Module 5 – Initiation, Monitoring and Addressing Potential Issues 

1. Determine goals of therapy and the initiation of cannabis therapy  

2. Review key factors when monitoring a patient on medical cannabis 

3. Examine the documentation recommendations for people taking cannabis  

4. Manage issues that may occur with patients taking cannabis  

Module 6 – Translating Cannabis Knowledge into Practice

1. Assess the potential benefits and risks of using medical cannabis in a diverse patient population  

2. Counsel a patient using cannabis for recreational purposes 

3. Evaluate factors that could affect the utilization of cannabis in specific patient populations 

4. Apply cannabis knowledge from this program to different patients seen in practice